Estadístiques de Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial
Visites totals
views | |
---|---|
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial | 58 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 3 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
Visites al fitxer
views | |
---|---|
perez-neo-tras.pdf | 26 |
perez-neo-tras.pdf(legacy) | 22 |
Vistes principals per país
views | |
---|---|
United States | 36 |
Sweden | 8 |
Spain | 5 |
Belgium | 3 |
Australia | 1 |
Ireland | 1 |
India | 1 |
Mongolia | 1 |
Malaysia | 1 |
New Zealand | 1 |
Visites principals per ciutat
views | |
---|---|
Ann Arbor | 7 |
Boardman | 7 |
San Ramon | 5 |
Fairfield | 4 |
Ashburn | 3 |
Barcelona | 3 |
Menlo Park | 3 |
Alella | 1 |
Alicante | 1 |
Auckland | 1 |
Cambridge | 1 |
Cupertino | 1 |
Dublin | 1 |
Mountain View | 1 |
Mumbai | 1 |
Pinjarra | 1 |
Sacramento | 1 |
San Diego | 1 |
Shah Alam | 1 |
Sükhbaatar | 1 |